Esmon C T
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Howard Hughes Medical Institute, Oklahoma City 73104, USA.
Crit Care. 2001;5(2):S7-12. doi: 10.1186/cc1333.
Thrombin is a multifunctional protein, with procoagulant, inflammatory and anticoagulant effects. Binding of thrombin to thrombomodulin results in activation of Protein C and initiation of the Activated Protein C anticoagulant pathway, a process that is augmented by the endothelial cell Protein C receptor (EPCR). Activated Protein C has demonstrated antithrombotic, anti-inflammatory, and profibrinolytic properties. Its antithrombotic activity is particularly important in the microcirculation, and Protein C deficiency is associated with microvascular thrombosis. Activated Protein C has also been shown to modulate inflammation. When the level of thrombomodulin or Protein C is reduced in sepsis there is a vicious cycle of coagulation and inflammation, with potentially lethal consequences. In vitro studies and animal models have shown that Activated Protein C blunts the inflammatory and coagulant response to sepsis through a variety of mechanisms.
凝血酶是一种多功能蛋白质,具有促凝血、炎症和抗凝作用。凝血酶与血栓调节蛋白结合会导致蛋白C激活并启动活化蛋白C抗凝途径,内皮细胞蛋白C受体(EPCR)会增强这一过程。活化蛋白C已显示出抗血栓形成、抗炎和促纤溶特性。其抗血栓形成活性在微循环中尤为重要,蛋白C缺乏与微血管血栓形成有关。活化蛋白C也已被证明可调节炎症。在脓毒症中,当血栓调节蛋白或蛋白C水平降低时,会出现凝血和炎症的恶性循环,可能导致致命后果。体外研究和动物模型表明,活化蛋白C通过多种机制减弱对脓毒症的炎症和凝血反应。